Cannabis treatment was associated with sustained reductions in patients’ pain intensity, opioid use, anxiety, depression, and sleep deprivation.
Search Results for: Study
“Treatment was associated with reductions in pain-specific patient-reported outcome measures at all time points in patients with osteoarthritis.”
“These findings, and others, refute hypothesized associations between cannabis use and low motivation. It is unfortunate that many of these longstanding stereotypes have historically guided public health messaging about cannabis and have also been used to stigmatize and discriminate against those who consume it responsibly.”
“Overall, the number of reported adverse effects were largely outnumbered by beneficial or null findings,” researchers determined.
Occasional cannabis consumers and controls “did not differ in internalizing psychopathology, cognitive functioning, or brain activity,” the study concluded.
Investigators concluded, “Our results suggest that cannabis should be considered as a strategy for harm reduction in opioid maintenance treatment.”
“These data indicate that the legal, regulated cannabis market is displacing the underground marketplace. Over time, consumers are becoming more comfortable with and more reliant upon licensed retailers – who typically offer greater convenience, product quality, and safety.”
Study subjects reported reduced stress, irritability, and anxiety following CBD dosing.